Neuro-Oncology Advances : Impact Factor & More
eISSN: 2632-2498
Open AccessShare this on:
Key Metrics
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Neuro-Oncology Advances
Neuro-Oncology Advances Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Oxford University Press |
| Language | English |
| Article Processing Charges | GBP 1500 | USD 2206 |
| Publication Time | 12 |
| Editorial Review Process | Peer review |
| General Details | |
| Publication Details | |
| Publication Time | 12 |
| Waiver Policy | Visit website |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Neuro-Oncology Advances ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Neuro-Oncology Advances
TLSB-27\u2003INTRACRANIAL ACTIVITY OF DATOPOTAMAB DERUXTECAN IN PATIENT-DERIVED MODELS OF BREAST CANCER BRAIN METASTASES
- 7 Aug 2026
- Neuro-Oncology Advances
MMDA-01\u2003LEPTOMENINGEAL DISEASE IN ALK-POSITIVE NSCLC: SURVIVAL IMPACT OF THIRD-GENERATION ALK INHIBITORS
- 7 Aug 2026
- Neuro-Oncology Advances
SADA-11\u2003A SCOPING REVIEW OF NUTRITIONAL STATUS IN THE CARE OF PATIENTS WITH METASTATIC SPINE DISEASE
- 7 Aug 2026
- Neuro-Oncology Advances
MMDA-09\u2003PROGNOSTIC DIFFERENCE BETWEEN HOMOGENEOUS VS. HETEROGENEOUS INTRACRANIAL RESPONSE OF MELANOMA BRAIN METASTASES TO IPILIMUMAB AND NIVOLUMAB
- 7 Aug 2026
- Neuro-Oncology Advances
RTAD-05\u2003LOCAL RECURRENCE AND RADIONECROSIS WITH 3-FRACTION STEREOTACTIC RADIOTHERAPY FOR POSTOPERATIVE CAVITIES AND INTACT BRAIN METASTASES: A PROSPECTIVE REGISTRY STUDY
- 7 Aug 2026
- Neuro-Oncology Advances
CLTR-01\u2003SURGICAL SELECTION PATTERNS IN NSCLC BRAIN METASTASES: CLINICAL AND MOLECULAR CORRELATES IN THE TKI ERA
- 7 Aug 2026
- Neuro-Oncology Advances
TLSB-27\u2003INTRACRANIAL ACTIVITY OF DATOPOTAMAB DERUXTECAN IN PATIENT-DERIVED MODELS OF BREAST CANCER BRAIN METASTASES
- 7 Aug 2026
- Neuro-Oncology Advances
MMDA-01\u2003LEPTOMENINGEAL DISEASE IN ALK-POSITIVE NSCLC: SURVIVAL IMPACT OF THIRD-GENERATION ALK INHIBITORS
- 7 Aug 2026
- Neuro-Oncology Advances
SADA-11\u2003A SCOPING REVIEW OF NUTRITIONAL STATUS IN THE CARE OF PATIENTS WITH METASTATIC SPINE DISEASE
- 7 Aug 2026
- Neuro-Oncology Advances
MMDA-09\u2003PROGNOSTIC DIFFERENCE BETWEEN HOMOGENEOUS VS. HETEROGENEOUS INTRACRANIAL RESPONSE OF MELANOMA BRAIN METASTASES TO IPILIMUMAB AND NIVOLUMAB
- 7 Aug 2026
- Neuro-Oncology Advances
RTAD-05\u2003LOCAL RECURRENCE AND RADIONECROSIS WITH 3-FRACTION STEREOTACTIC RADIOTHERAPY FOR POSTOPERATIVE CAVITIES AND INTACT BRAIN METASTASES: A PROSPECTIVE REGISTRY STUDY
- 7 Aug 2026
- Neuro-Oncology Advances
CLTR-01\u2003SURGICAL SELECTION PATTERNS IN NSCLC BRAIN METASTASES: CLINICAL AND MOLECULAR CORRELATES IN THE TKI ERA
- 7 Aug 2026
- Neuro-Oncology Advances
FAQs on Neuro-Oncology Advances
How many articles did Neuro-Oncology Advances publish last year? 
Who is the publisher of Neuro-Oncology Advances?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations